Form D · Other Health Care

ASCENDIA PHARMACEUTICALS, INC.

North Brunswick, NJ · CIK 0001855888

Offering snapshot reported Jul 24, 2026 · SEC filing

Reported sold
$4.08M
Offering amount: $4.08M
Investors reported
3
Form D · investor count
Minimum accepted
$500K
Reported outside-investor minimum
First sale
Jun 26, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 24, 2026Initial$4,084,536No comparison3SEC filing
Jun 4, 2025Initial$2,500,000No comparison9SEC filing
Oct 11, 2024Initial$2,500,638No comparison2SEC filing
Jul 13, 2022Initial$2,499,945No comparison2SEC filing
Apr 20, 2021Initial$4,999,999No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-592056

Source: Form D, filed Jul 24, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Bloder Director
Michael Bogda Director
Colin Foster Director
James Gale Director
Jingjun Huang Director
Shoufeng Li Director
Theron Odlaug Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
661 Us Highway One Unit B
North Brunswick, NJ, 08902
Phone: 7326400058